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Many organs develop from close inductive interactions be-
tween a differentiating epithelium and its surrounding mesen-
chyme, and the kidney is no exception [1]. Molecules of the
extracellular matrix have long been recognized to mediate
interactions between embryonic cells; they are essential for cell
adhesion, polarity and migration, and are able to induce cell
differentiation [1]. It is therefore interesting to identify extra-
cellular matrix components that accumulate preferentially in
places where different cell types interact and that appear and
disappear in the course of organ formation. Tenascin (also
known as hexabrachion, Jl-220 and cytotactin), has drawn
attention precisely because it has a restricted pattern of expres-
sion which almost always correlates with morphogenetic events
[2—4]. For example, tenascin accumulates specifically in the
dense mesenchyme surrounding epithelial organ anlagen [5]. It
can disappear later in development but is re-expressed in the
stroma of tumors [5]. Little tenascin is found in adult skin but
large amounts accumulate during wound healing [6]. Tenascin is
a prominent component of extracellular matrix in the develop-
ing central nervous system [4], and is permanently found in
some tissues under mechanical stress such as periosteum,
tendons, and smooth muscle [2].
Recent reviews describe isolation and expression of tenascin
[2], its primary structure derived from cDNA cloning [3], and its
putative functions [2—4]. The present article concentrates on the
expression and function of tenascin in epithelial organs, among
them the kidney.
Structure of tenascin, and implications for function
Tenascin is an oligomeric glycoprotein with a molecular mass
of more than one million daltons and disulfide-linked subunits of
190 to 250 kDa [2-41. Viewed in the electron microscope after
rotary shadowing, most tenascin particles look like a large
insect with six extended limbs, hence the name hexabrachion
[2, 4]. Two pairs of three arms each emanate from opposite
sides of a central globular domain. The proximal third of each
arm is very thin, whereas the distal part is thicker, more flexible
and ends in a globule at its tip. Each arm corresponds to a single
subunit [2—4].
The primary amino acid sequence of tenascin subunits re-
veals a linear array of repeated structural domains [3, 7]. Close
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to the N-terminus, so-called heptad repeats flanked by cys-
teines are involved in connecting subunits to triplets. This
region is followed by 13 or 14 repeats containing six cysteines
each, which are homologous to epidermal growth factor (EGF).
More distally, there are domains resembling the type III do-
mains in fibronectin, which can vary in number from 8 to 15 as
a result of various mRNA splicing variants. At the C-terminus,
each subunit possesses a region homologous to fibrinogen [3, 7].
Mapping with monoclonal antibodies established that the thin
inner part of the tenascin arms corresponds to EGF-like re-
peats, the thicker distal region to the fibronectin type III repeats
and the distal globule to the fibrinogen homologue [7].
The extended oligomeric domain structure suggests that
tenascin interacts multivalently with cell surfaces and other
extracellular matrix components. EGF-like domains are struc-
tural motifs present in other extracellular components and
might be involved in cell signalling, although there is no
evidence yet for tenascin. In fibronectin, the type III repeats
contain several recognition signals for cell-surface adhesion
receptors. The most famous is the amino acid sequence Arg-
Gly-Asp (ROD) which binds to a heterodimeric fibronectin
receptor of the integrin family. Chick and human tenascin do
contain an RGD sequence in one of the type III repeats [31, and
an integrin has been reported to bind to human tenascin in an
ROD-dependent manner [2]. The RGD sequence is, however,
not conserved in mouse tenascin, hence its function remains
controversial [3]. Despite their structural similarities, fibronec-
tin and tenascin have very different effects on cells: whereas
fibronectin mediates attachment and spreading of most cell
types, tenascin is a poor cell attachment protein [3, 8]. Instead,
it is a potent hemagglutinin [5] and can inhibit cell spreading [8]
on fibronectin substrates. All these effects are reversed by a
monoclonal antibody which binds to a type III repeat of chick
tenascin subunits [8]. This domain, therefore, contains an
RGD-independent cell-interaction site for which a cell surface
receptor has not yet been identified.
As well as mediating interactions with cells, the fibronectin
type III repeats could have other functions. Tenascin is able to
interact with other extracellular matrix components such as
proteoglycans and fibronectin [3, 8] and, although binding
domains have not yet been localized, type III repeats are good
candidates. Extra type III repeats found in tenascin variants are
highly glycosylated [7] and might be involved in regulation of
turnover for they are preferentially cleaved by proteases [9].
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Expression of tenascin in epithelial organs
One way to approach the function of tenascin is to study its
expression pattern both in space and time. As mentioned
above, tenascin appears and disappears in the course of mor-
phogenetic events: it surrounds growing epithelia, is associated
with pathways of migratory cells, and outlines developing
skeletal elements [2—4]. The following summarizes published
information on the occurrence of tenascin in a few developing
epithelial organs.
Mammary gland
Development of the rat mammary gland starts by infolding of
the thickened epidermis at future nipple sites. At the same time,
tenascin appears in the dense mesenchyme immediately sur-
rounding the primary duct epithelium [5]. In contrast, the
protein is not associated with elongating mammary ducts while
they invade the fat pad precursor tissue [10]. In the juvenile
gland, tenascin appears again at the onset of acinar differenti-
ation around the developing endbuds [101. In the normal adult
mammary gland no tenascin is found [5], not even during
pregnancy when acinar proliferation takes place [10]. However,
tenascin is reexpressed in the stroma surrounding mammary
carcinomas [5, 101. This very restricted pattern of expression
shows that tenascin is not simply associated with every growing
epithelium, but only with certain steps of epithelial morphogen-
esis.
Several data indicate that mammary epithelial cells do not
themselves produce tenascin, but are able to induce tenascin
synthesis by nearby mesenchymal cells [10]. One inducing
factor might be transforming growth factor beta (TGF-/3), since
cultured mammary carcinoma cells can stimulate tenascin syn-
thesis in adjacent fibroblasts, and since this activity was shown
to be due to TGF-j3 [11].
Lung
In the developing chick lung, tenascin is again accumulated
locally in the mesenchyme around the tips of growing primary
and secondary bronchi [12, 13]. In this case, the protein is also
found associated with the basement membrane at the tips of
developing epithelial tubes, but disappears along their shafts
[131. In contrast to what is seen in the mammary gland, in this
case the lung epithelium is clearly the biosynthetic source of
tenascin. In situ hybridization shows that only the most distal
epithelial cells of every bronchial branch produce tenascin
mRNA [12, 13].
Kidney
During kidney differentiation in mammals, a growing ureter
bud induces the surrounding mesenchyme first to condense,
then to convert to an epithelial structure called S-shaped body
from which a tubule and a glomerulus develops. Tenascin is first
detectable around the mesenchymal condensates at the onset of
epithelialization [14, 15], It is then strongly expressed in the
stroma just surrounding the S-shaped bodies, and is so far the
only marker for this specialized mesenchyme [14, 15]. In a
newborn mouse where tubular and glomerular differentiation is
still occurring, tenascin is found throughout the kidney cortex,
from where it later disappears completely [14]. Thus, also in the
developing kidney there is a clear correlation between tenascin
expression and certain steps of epithelial morphogenesis.
Since in the developing kidney tenascin is found in the stroma
surrounding forming epithelia but not in their basement mem-
branes, it is likely to be produced by mesenchymal cells in
response to an inductive signal from the epithelium [14, 15].
This would be similar to the case of mammary gland but
different from lung. Localization of tenascin mRNA in the
differentiating kidney will clarify this point.
Putative function of tenascin in epithelial-mesenchymal
interactions
In the few years since tenascin was first isolated, its primary
sequence has been solved and correlated to protein domain
structure [3, 7]. Its fascinating patterns of expression during
development of epithelial organs strongly suggest an indispen-
sible function for growth and morphogenesis of certain epithelia
[2, 4]. From this work, hypotheses on tenascin function have
been put forward that are based largely on correlations. But
how tenascin is integrated into the extracellular matrix and how
it acts on cells in molecular terms remains largely unknown, for
the following reasons. First, in contrast to other extracellular
matrix proteins, tenascin has no clear-cut, unquestionable
activity in the standard adhesion or migration assays in vitro
[2—4]. Instead, its influence on cell shape and motility depends
very much on the assay conditions used, that is, on the cells and
on the presence of other molecules bound to the substrate or in
the medium [8]. Second, no major ligand of high affinity has yet
been identified for tenascin, either in the extracellular matrix or
on cell surfaces. Matrix and cell surface proteoglycans, fi-
bronectin, collagens, and integrins are all good candidates, but
binding can be demonstrated only when one ligand is immobi-
lized, and affinity and yields are low [2—4].
Thus, the identification of physiologically relevant ligands for
tenascin, both cellular and extracellular, remains a serious
problem. An important functional feature of this molecule might
be to establish multiple low affinity interactions with many
different partners and so modulate interactions of cells with
each other or with extracellular matrix in complex ways. This
could partly explain the sometimes contradictory results ob-
tained by in vitro experiments. Although this is easily said, it is
hard to prove, because it makes the dissection of tenascin into
discrete active domains a difficult task. Along these lines, it has
been postulated that tenascin has (at least) two domains with
contrary but interdependent functions [7, 8]. Cells are thought
first to attach to an adhesive domain on tenascin. This binding
then allows the cells to interact with a different tenascin domain
which induces them to round up and actively detach [7, 8]. This
remains a hypothesis as long as the cell surface receptors are
unknown; their identification is a prime goal of future research.
Despite these missing links, enough data are available to
speculate about the function of tenascin in developing epithelial
organs in more general terms. Tenascin is a molecule either
secreted by certain epithelial cells themselves [12, 13], or its
synthesis is induced by epithelial cells in the surrounding
mesenchyme [10, 14]. Usually, its expression is restricted to
phases of active epithelial growth or movement. To take
developing lung buds as an example, tenascin is secreted by the
epithelial cells in a polarized way, that is, at their future basal
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surface towards the interstitial matrix [13]. Tenascin might
cause mesenchymal cells to retract [81, thereby allowing the
epithelial cells to slide along the dense and adhesive interstitial
matrix on their basal side while they maintain structural integ-
rity of the tube via their lateral cell surfaces. Thus, tenascin
could facilitate penetration of growing epithelial tubes into the
mesenchyme [13]. At the same time, tenascin-containing matrix
could form transient, flexible boundaries between epithelium
and mesenchyme, which only later are replaced by stable
structures such as mature basement membranes. In addition,
tenascin might be important for epithelial cell growth since it
has been shown to be mitogenic for mammary epithelial cells,
either by itself or by binding growth factors [5]. Tenascin might
therefore be involved in various inductive events between
developing epithelia and their surrounding stroma. Cocultures
of epithelial with mesenchymal cells, as well as perturbation
experiments with domain-specific tenascin probes in vitro and
in vivo, are needed to test these hypotheses further.
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